Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Baricitinib works better than methotrexate for severe alopecia areata.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

Tofacitinib is an effective and safe treatment for alopecia areata.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Lichen planopilaris can cause patchy hair loss in children and may respond to certain treatments.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Imuvert can prevent some chemotherapy-induced hair loss.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Systemic retinoids may effectively treat erosive pustular dermatosis of the scalp.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Children with marasmus have more resting hair follicles and thinner, less pigmented hair, showing long-term malnutrition.

The combined therapy was effective and safe for children with severe alopecia areata.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.